Vascular Stents Market Registers Steady Growth owing to Demand for Minimally Invasive Surgeries
Vascular stents are tiny wire mesh tubes placed into blood vessels, arteries or other hollow structures to open the blockage of vessels. The process for placement of vascular stent into body is known as vascular stenting. Vascular stenting is considered as a valuable tool for applications of non-coronary vasculature. These stents are used to open narrowed vessels and reduce the chances of chest pain or heart attack. Most of the stents are made up of metal or plastic mesh like materials. There are commonly two types of stents namely bare metal stents and covered stents, also called as stent grafts.
The rising aging population will be a major driving factor for the global vascular stents market, state the analysts. As per the findings of the World Health Organization (WHO), in 2000 there were 605 million people aged 65 years or more. The number is projected to reach 2 billion by 2050. Additionally, technological advancements in medical devices are anticipated to propel the global market for vascular stents.
Vascular stents have taken over the conventional surgical methods due to their advantages such as short recovery time, minimized bleeding, minimal risk of infection, and low cost. However, manufacturers of vascular stents are predicted to face the biggest challenge of the availability of alternative therapies.
Obtain the Future Market Projections for Vascular Stents at: http://bit.ly/2gJdLoi
The report segments the global vascular stents market on the basis of region and material. Metal stents, biodegradable polymeric stents, and standard polymeric stents are the primary types of vascular stents.
By geography, the global vascular stents market is divided into Europe, Asia Pacific, North America, and Rest of the World. Currently, North America leads the global market for vascular stents owing to the rising number of people suffering from cardiovascular diseases. Europe follows North America to be the second largest market for vascular stents. The rising preference of surgeons to use newly introduced vascular stents to treat cardiovascular diseases will propel the vascular stents market in Europe, predict the analysts. Increasing government funding in China, India, and South-East Asia is projected to propel this market in Asia Pacific.
The research evaluates company profiles of leading participants operating in this market to present a competitive landscape. Some of the prominent players listed in the report are Cook Medical, InnoCore Technologies BV, Cordis Corporation, MIV Therapeutics Inc., Boston Scientific Corporation, Translumina GmbH, Stentys SA, SurModics Inc., Xtent Inc., Goodman Co. Ltd., Abbott Laboratories, Biosensors International Ltd., Reva Medical Inc., MicroPort Scientific Corp., Allvivo Vascular Inc., and Medtronic, Inc.